Latest news
Loading news…
Dizal Pharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Shanghai, China Founded 2017 501-1000 employees For Profit
Dizal Pharma is a biotechnology company that conducts research for the treatment of cancer and immunological diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
9
Ticker
688192
SSE - Shanghai Stock Exchange
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- 688192
- Exchange
- SSE - Shanghai Stock Exchange
- IPO date
- Dec 10, 2021
- Raised at IPO
- $312M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 28
Company Info
- Founded
- 2017
- Employees
- 501-1000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 29
- HQ
- Shanghai, China
- Region
- Asia-Pacific (APAC)
- Exit date
- Dec 10, 2021
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.6
- Trend (30d)
- -2.2
- Trend (90d)
- -1.3
9
professional contacts at Dizal Pharma
Contact execs at Dizal Pharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Dizal Pharma
Loading news…
FAQs about Dizal Pharma
People who checked this page also checked these
Browse the full Acquirezy directory.